Ann E. Wiringa

829 total citations
24 papers, 661 citations indexed

About

Ann E. Wiringa is a scholar working on Epidemiology, Infectious Diseases and Modeling and Simulation. According to data from OpenAlex, Ann E. Wiringa has authored 24 papers receiving a total of 661 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Epidemiology, 12 papers in Infectious Diseases and 8 papers in Modeling and Simulation. Recurrent topics in Ann E. Wiringa's work include Influenza Virus Research Studies (9 papers), COVID-19 epidemiological studies (8 papers) and Vaccine Coverage and Hesitancy (7 papers). Ann E. Wiringa is often cited by papers focused on Influenza Virus Research Studies (9 papers), COVID-19 epidemiological studies (8 papers) and Vaccine Coverage and Hesitancy (7 papers). Ann E. Wiringa collaborates with scholars based in United States, Switzerland and United Kingdom. Ann E. Wiringa's co-authors include Bruce Y. Lee, Rachel R. Bailey, Richard H. Beigi, Kenneth J. Smith, Richard K. Zimmerman, Robert R. Muder, Shawn T. Brown, Donald S. Burke, Tina-Marie Assi and Jayant Rajgopal and has published in prestigious journals such as PLoS ONE, Clinical Infectious Diseases and American Journal of Public Health.

In The Last Decade

Ann E. Wiringa

24 papers receiving 638 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ann E. Wiringa United States 16 317 247 203 158 50 24 661
Marc Rondy United States 14 542 1.7× 219 0.9× 156 0.8× 83 0.5× 32 0.6× 30 748
William John Edmunds United Kingdom 10 336 1.1× 251 1.0× 60 0.3× 149 0.9× 34 0.7× 10 635
Ana Navascués Spain 18 503 1.6× 438 1.8× 158 0.8× 143 0.9× 32 0.6× 67 911
Lorna Willocks United Kingdom 18 292 0.9× 214 0.9× 190 0.9× 58 0.4× 32 0.6× 43 772
Chiara Paganino Italy 18 596 1.9× 192 0.8× 207 1.0× 57 0.4× 52 1.0× 32 739
Ian D. Plumb United States 12 166 0.5× 322 1.3× 107 0.5× 96 0.6× 38 0.8× 42 596
Clayton Chiu Australia 17 627 2.0× 281 1.1× 249 1.2× 81 0.5× 144 2.9× 30 1.0k
Gillian Lim Canada 14 464 1.5× 269 1.1× 227 1.1× 197 1.2× 51 1.0× 22 866
Salah Al Awaidy Oman 17 360 1.1× 407 1.6× 218 1.1× 100 0.6× 43 0.9× 89 900
Anke L. Stuurman Belgium 10 389 1.2× 266 1.1× 88 0.4× 67 0.4× 21 0.4× 26 629

Countries citing papers authored by Ann E. Wiringa

Since Specialization
Citations

This map shows the geographic impact of Ann E. Wiringa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ann E. Wiringa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ann E. Wiringa more than expected).

Fields of papers citing papers by Ann E. Wiringa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ann E. Wiringa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ann E. Wiringa. The network helps show where Ann E. Wiringa may publish in the future.

Co-authorship network of co-authors of Ann E. Wiringa

This figure shows the co-authorship network connecting the top 25 collaborators of Ann E. Wiringa. A scholar is included among the top collaborators of Ann E. Wiringa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ann E. Wiringa. Ann E. Wiringa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Matthias, James, et al.. (2021). Epidemiologically Linked COVID-19 Outbreaks at a Youth Camp and Men’s Conference — Illinois, June–July 2021. MMWR Morbidity and Mortality Weekly Report. 70(35). 1223–1227. 6 indexed citations
2.
Wiringa, Ann E., Roberta B. Ness, Toni Darville, Richard H. Beigi, & Catherine L. Haggerty. (2019). Trichomonas vaginalis, endometritis and sequelae among women with clinically suspected pelvic inflammatory disease. Sexually Transmitted Infections. 96(6). 436–438. 32 indexed citations
3.
Wiringa, Ann E., Kathleen A. Shutt, Jane W. Marsh, et al.. (2013). Geotemporal Analysis of Neisseria meningitidis Clones in the United States: 2000–2005. PLoS ONE. 8(12). e82048–e82048. 6 indexed citations
4.
Lee, Bruce Y., Tina-Marie Assi, Diana L. Connor, et al.. (2011). Replacing the measles ten-dose vaccine presentation with the single-dose presentation in Thailand. Vaccine. 29(21). 3811–3817. 43 indexed citations
5.
Lee, Bruce Y., Kristina M. Bacon, Julie M. Donohue, et al.. (2011). From the patient perspective: The economic value of seasonal and H1N1 influenza vaccination. Vaccine. 29(11). 2149–2158. 27 indexed citations
6.
Song, Yongdong, Sarah M. McGlone, Rachel R. Bailey, et al.. (2011). The economic value of screening haemodialysis patients for methicillin-resistant Staphylococcus aureus in the USA. Clinical Microbiology and Infection. 17(11). 1717–1726. 18 indexed citations
7.
Lee, Bruce Y. & Ann E. Wiringa. (2011). The 2009 H1N1 influenza pandemic. Human Vaccines. 7(1). 115–119. 12 indexed citations
8.
Lee, Bruce, Shawn T. Brown, Phillip Cooley, et al.. (2010). Continuation of Vaccination Deep into a Pandemic Wave: Potential Mechanisms for a "Third Wave" and the Impact of Vaccination. American Journal of Preventive Medicine. 39(5). 2 indexed citations
9.
Lee, Bruce Y., et al.. (2010). The Economic Effect of Screening Orthopedic Surgery Patients Preoperatively for Methicillin-ResistantStaphylococcus aureus. Infection Control and Hospital Epidemiology. 31(11). 1130–1138. 38 indexed citations
10.
Lee, Bruce Y., Shawn T. Brown, Philip C. Cooley, et al.. (2010). Vaccination Deep Into a Pandemic Wave. American Journal of Preventive Medicine. 39(5). e21–e29. 35 indexed citations
11.
Lee, Bruce Y., Rachel R. Bailey, Ann E. Wiringa, et al.. (2010). Economics of employer-sponsored workplace vaccination to prevent pandemic and seasonal influenza. Vaccine. 28(37). 5952–5959. 37 indexed citations
12.
Lee, Bruce Y., Sarah M. McGlone, Rachel R. Bailey, et al.. (2010). To Test or to Treat? An Analysis of Influenza Testing and Antiviral Treatment Strategies Using Economic Computer Modeling. PLoS ONE. 5(6). e11284–e11284. 40 indexed citations
13.
Lee, Bruce Y., et al.. (2010). Staphylococcus aureus vaccine for orthopedic patients: An economic model and analysis. Vaccine. 28(12). 2465–2471. 27 indexed citations
14.
Lee, Bruce Y., Kristina M. Bacon, Rachel R. Bailey, Ann E. Wiringa, & Kenneth J. Smith. (2010). The potential economic value of a hookworm vaccine. Vaccine. 29(6). 1201–1210. 22 indexed citations
15.
Lee, Bruce Y., Rachel R. Bailey, Ann E. Wiringa, et al.. (2010). The potential economic value of a Staphylococcus aureus vaccine for neonates. Vaccine. 28(29). 4653–4660. 8 indexed citations
16.
Lee, Bruce Y., et al.. (2010). Screening cardiac surgery patients for MRSA: an economic computer model.. PubMed. 16(7). e163–73. 21 indexed citations
17.
Lee, Bruce Y., et al.. (2010). The potential value of Clostridium difficile vaccine: An economic computer simulation model. Vaccine. 28(32). 5245–5253. 45 indexed citations
18.
Lee, Bruce Y., Bryan A. Norman, Tina-Marie Assi, et al.. (2010). Single versus multi-dose vaccine vials: An economic computational model. Vaccine. 28(32). 5292–5300. 84 indexed citations
19.
Lee, Bruce Y., Rachel R. Bailey, Ann E. Wiringa, Tina-Marie Assi, & Richard H. Beigi. (2009). Antiviral Medications for Pregnant Women for Pandemic and Seasonal Influenza. Obstetrics and Gynecology. 114(5). 971–980. 15 indexed citations
20.
Beigi, Richard H., et al.. (2009). Economic Value of Seasonal and Pandemic Influenza Vaccination during Pregnancy. Clinical Infectious Diseases. 49(12). 1784–1792. 82 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026